Korean Market
EXCH
Green Cross Medical Science
★★

Exercise Price Adjustment for 5th Series BW from 4,043 KRW to 2,831 KRW, Potential Dilution of 16% Raises Concerns for Existing Shareholders

 
OWNR
Green Cross Medical Science
★

GC Biopharma Stake in Green Cross Medical Science Dilutes to 47% from 51.6% Following Warrant Exercises

 
OWNR
Green Cross Medical Science
★

Green Cross Medical Science Registered Executive Kim Won-gi Increases Stake via Open Market Purchase; Outstanding Shares Rise 9.3% from Stock Option Exercise

 
OWNR
Green Cross Medical Science
★

Green Cross Medical Science CEO Kim Yeongeun Increases Stake to 0.18% via Open Market Purchases

 
OWNR
Green Cross Medical Science
★

Green Cross Medical Science CEO Yeongeun Kim Buys 2,500 Shares, Raising Stake to 0.17%

 
EXCH
Green Cross Medical Science
★

Warrant Exercise Dilutes Equity by 6.7% at 4,043 Won

 
EXCH
Green Cross Medical Science
★

Exercise of 5th BW Warrants for 766,746 Shares (3.5%) - Exercise Price 4,043 Won

 
PERI
Green Cross Medical Science
★

GCMS: Q1 2026 Revenue Down, Net Profit Turns Positive

 
EXCH
Green Cross Medical Science
★

Preliminary Q1 2026 Results: Revenue and Operating Profit Decline, Net Income Turns Positive

 
EXCH
Green Cross Medical Science
★

GC Medical Science Corporation Announces English Name Change